Company Overview - Stevanato Group operates with a global footprint and an integrated value proposition, reporting its numbers in two segments: Biopharmaceutical and Diagnostic Solutions (approximately 85% of revenue) and Engineering (about 15% of revenue) [1] Biopharmaceutical and Diagnostic Solutions - The core business focuses on drug containment solutions, offering three main formats: pre-filled syringes, vials, and cartridges, with options for both bulk and sterile configurations [2] - The company is shifting towards high-value products, specifically in Nexa and Alba configurations [2] - Investments in drug delivery systems began five years ago, with notable progress in proprietary products such as pen injectors, auto-injectors, and on-body delivery systems [3] - The company also has a presence in the in-vitro diagnostic business [3] Engineering Segment - The Engineering segment provides visual inspection machines, primarily for the pharmaceutical industry [3]